Pleuropulmonary blastoma, an aggressive tumor that is emerging as a distinc
t entity of childhood, is characterized by mesenchymal elements (including
undifferentiated blastema and often cartilaginous, rhabdomyoblastic, or fib
roblastic differentiation) and epithelium-lined spaces. We investigated two
patients with pleuropulmonary blastoma, a 3-year-old boy and an 11-year-ol
d girl, both with large cystic masses replacing one lung. In both children,
the post-chemotherapy resection specimens showed more maturation of rhabdo
myoblasts and more nuclear pleomorphism in all mesenchymal cell lines, comp
ared with biopsies sampled before treatment. Karyotypic analysis demonstrat
ed gains in chromosome 8 in both cases and 17p deletion in one case. Fluore
scent in situ hybridization analysis demonstrated that the chromosome 8 gai
ns were present in all mesenchymal elements, including undifferentiated bla
stematous, rhabdomyoblastic, fibroblastic, and chondroblastic areas. Epithe
lial cells showed no chromosome 8 gains. The chromosome 8 aberrations were
not appreciably different in pre- versus post-chemotherapy tissue. Our find
ings substantiate previous reports that polysomy of chromosome 8 is a consi
stent feature of pleuropulmonary blastoma. Further, they indicate that clon
al proliferation in pleuropulmonary blastoma is restricted to the malignant
mesenchymal elements, supporting the notion that the epithelial components
of this tumor are non-neoplastic.